Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET-AML - Value of 18FDG-PET-CT in Patients With AML for Detection of Extramedullary AML Manifestations

NCT01278069 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT01278069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET-AML - Value of 18FDG-PET-CT in Patients With AML for Detection of Extramedullary AML Manifestations
Lead sponsor
Technische Universität Dresden
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
September 30, 2013
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed or relapsed acute myeloid leukemia